Blurbs

Analysts Have Conflicting Sentiments on These Technology Companies: Paychex (PAYX), 2U (TWOU) and Accolade (ACCD)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on Paychex (PAYXResearch Report), 2U (TWOUResearch Report) and Accolade (ACCDResearch Report).

Paychex (PAYX)

In a report issued on June 30, Mark Marcon from Robert W. Baird maintained a Hold rating on Paychex, with a price target of $133.00. The company’s shares closed last Friday at $116.36.

According to TipRanks.com, Marcon is a 5-star analyst with an average return of 14.3% and a 55.5% success rate. Marcon covers the Technology sector, focusing on stocks such as Automatic Data Processing, Ceridian HCM Holding, and Sterling Check.

Paychex has an analyst consensus of Hold, with a price target consensus of $129.73, implying a 13.6% upside from current levels. In a report issued on June 29, Evercore ISI also maintained a Hold rating on the stock with a $116.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

2U (TWOU)

Robert W. Baird analyst Jeffrey Meuler maintained a Buy rating on 2U on June 29 and set a price target of $14.00. The company’s shares closed last Friday at $12.25, close to its 52-week low of $7.28.

According to TipRanks.com, Meuler is a 3-star analyst with an average return of 2.3% and a 51.9% success rate. Meuler covers the Services sector, focusing on stocks such as Adtalem Global Education, Grand Canyon Education, and Nielsen Holdings.

2U has an analyst consensus of Moderate Buy, with a price target consensus of $19.14, an 82.8% upside from current levels. In a report issued on June 30, Needham also maintained a Buy rating on the stock with a $19.00 price target.

Accolade (ACCD)

Robert W. Baird analyst Vikram Kesavabhotla maintained a Buy rating on Accolade on June 30 and set a price target of $9.00. The company’s shares closed last Friday at $9.53, close to its 52-week low of $4.61.

According to TipRanks.com, Kesavabhotla is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -15.0% and a 33.3% success rate. Kesavabhotla covers the Technology sector, focusing on stocks such as Definitive Healthcare Corp, Tabula Rasa HealthCare, and InnovAge Holding.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Accolade with a $10.54 average price target, a 39.6% upside from current levels. In a report issued on June 30, Jefferies also maintained a Buy rating on the stock with a $13.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on PAYX:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos